This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. This issue profiles research by Sandia for boosting thermoelectric nanowire efficiency, gold nanoprobes for cancer diagnostics, and Sandia research on converting biological cells to stone

    $250.00
  2. This issue profiles a fully integrated, high capacity, next generation sequencing system; an ebola diagnostic kit by China that has been approved by the WHO; and CRISPR associated protein 9 mediated gene editing in human embryo.

    $250.00
  3. 10 Jun 2015  |  Asia Pacific  |  Market Outlook

    Vietnam Healthcare Outlook

    Value Propositions and Market Entry Guides for Investors

    This research service provides an analysis for the healthcare market in Vietnam. In addition to an overview of the total healthcare market, it presents detailed analyses of current trends, market sizes, revenue forecasts, and drivers and restraints for the hospital (private and public) market, and for the manufacturing and distribution of medical d...

    $4,950.00
  4. This issue profiles research that has identified a variant of gene type linking cholesterol with cardiovascular disease; a genetic variant that identifies the likelihood of patient's response to treatment for multiple sclerosis, and cancer treatment by telomere inhibition.

    $250.00
  5. This issue profiles recent advances and opportunities for innovation in drug-eluting stents.

    $750.00
  6. This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.

    $250.00
  7. This issue profiles a molecular pathway that holds the key to suppress children's cancer, destroying chemical weapons safely, and R&D on datacenter cabling at HP Laboratories.

    $250.00
  8. This issue profiles an affordable and customisable radiotherapy system, a remote telerobotic ultrasound imaging platform, and affordable digital radiography systems for low-income countries.

    $950.00
  9. This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

    $250.00
  10. 18 May 2015  |  Asia Pacific  |  Market Outlook

    2015 Asia-Pacific Healthcare Industry Outlook

    APAC will Continue to Remain in Global Spotlight for Investment, Innovation, and Growth in Healthcare

    The research service provides an analysis of the healthcare market in Asia-Pacific (APAC). It discusses the current technology and country-specific trends and provides predictions. Market participants and key opinion leaders in APAC hospitals were interviewed to obtain their views on trends and opportunities in the healthcare industry. The regional...

    $2,450.00